IMCAS

Cosmeceuticals & Nutraceuticals

CAMPOMATS - Microneedling for regenerative medecine through cosmeceuticals delivery

LABORATOIRES URGO - Smart DNA therapy: Antioxidant and anti-inflammatory therapy to support and modulate the natural skin microbiome. Protection and repair of skin cell DNA. Clinical case study by Retix.C

ROSEWAY LABS - Personalised skincare using compounded medication

Objectives: • Understand the value that a compounding pharmacy can offer to dermatology patients in the private sector
• Learn about popular formulations that benefit patients with skin conditions and hair disorders
• See how compounds can transform your offering to your patients

Introduction: Compounding pharmacies typically support primary healthcare with drugs that are not available in licensed form. Often, these are approved by insurers and prescribers are limited to what is on the list.

Materials / method: A new way to think about compounding is for private patients who want something different that actually works. In the UK, clinics use compounded medication for acne, hyperpigmentation, rosacea, anti-ageing, dermatitis, alopecia, male and female pattern baldness and vaginal atrophy. Ingredients such as: tretinoin, glycolic acid, azelaic acid, hydrocortisone, hydroquinone, hyaluronic acid, caffeine, minoxidil and finasteride are frequently used either alone or in combination. Many other active ingredients, hormones, vitamins and cosmeceuticals are worked with as well.

Results: Having patients use compounded medication on a regular basis can help a clinic’s revenues and enhance its reputation as customers feel great. Monthly or quarterly prescriptions ensure that patients continue with a topical regime and can move onto different combinations of ingredients as the ageing process develops.

Conclusion: Roseway Labs is opening up a compounding pharmacy in the EU so that patients and prescribers can benefit from the same products and approach that has transformed the UK dermatology market. With electronic prescribing allowing clinicians to create their own combinations of active ingredients and eLearning to show the way, we predict that compounded medications will be soon seen through a completely different lens.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

DERMOAROMA - Purasomes XCell : Improving clinical outcome with new generation of bovine colostrum sublingual supplement

EURORESEARCH - Collagen overwiev

CANTABRIA LABS - All skin med: Dispensing doctor cosmetic range and its new solutions to activate and reinforce the skin barrier function

ROC SKINCARE - RoC35: 35 French clinics researching the ultimate skin rejuvenation skincare routine

FAGRON GENOMICS - SNP association analysis: A novel pathway towards personalised treatment for androgenetic alopecia

INSTITUTE BCN - Duo-Action PRP: Enhancing hair loss and alopecia treatment with botox and meostherapy

DERMAROLLER - Revolutionizing skin and hair care: The next-gen microneedling device and hair growth science

SPRING THREAD - Permanent / Resorbable : Why and how to choose the best aesthetic thread according to your patient request or indication

REGENERA ACTIVA - EVOlution of autologous micrografting; 3rd generation of rigenera techology

DERMOAROMA - Bovine colostrum secretomes application in regenerative and functional gynaecology

DERMOAROMA - Unlocking bio rejuvenation with bovine colostrum secretomes

PLURYAL - Portrait of patients for polynucleotides and exosomes

RENAISSANCE - Accelerated regeneration : Integrating PDRN & exosomes therapy with MIO-Modulated pulse stimulation for enhanced skin cellular renewal

ALLIER PARIS - Discover the science behind enjoue: The new generation of whitening, lifting & bio revitalizing

Objectives: The aim of the study is to prove the effectiveness of a combination between an HA Skin booster and a patented whitening peptide on slowing down the ageing process

Introduction: The ageing process is characterised biologically by a reduction of extracellular matrix cells specially the fibroblast with a reduction of collagen and elastin production; therefore we assist to a degradation of collagen and elastin fibers by free radical oxygen species leading to an important collagen structure alteration

Materials / method: Enjoue in a biorevitalizer with a minor cross-linked hyaluronic Acid combining 2 molecular weights 1500/1000 Kdalton. The new minor cross-linking technology insures a long lasting result on the skin hydration & texture improvement.
. Years of scientific researches have lead to Genowhite by enjoué, the first whitening biorevitalizer, containing a patented advanced peptide : Acety Glycol Beta alanine capable to contrast effectively the skin hyperpigmentation by inhibition of the three core signal of the regulation of Melanogenesis.

Results: Genowhite has 3 essential effects: Inhibition of melanosom transport (Melanophilin), Inhibition of all melanin generating enzymes as tyrosine, Tyrosine Related Protein 1 ( TRP1) & TRP2, Down regulate the master regulator-microphtalmia-associated transcription factor (MITF).Additionally Acetyl glycol beta alanine is able to contrast Melanogen Cytokins production SCF & ET-1 and pollutant induced Melanogenesis.

Conclusion: in conclusion there is a rational in combining Hyaluronic Acid Skin booster with the patented withening Amino Acid Acety Glycol Beta alanine as hyaluronic effect as an inflammatory effect, and also the inflammation is one of the main factor of hyperpigmentation.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): allier

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): allier

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No
Por favor especifique las entidades (individuo, empresa, sociedad): allier

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: allier

BAZ BIOMEDIC - Innovative combination therapies utilizing Needle-Free Jet Injector

Objectives: The aim of this presentation is to explore the clinical efficacy and benefits of using third-generation needle-free jet injectors (NovoJet and CureJet) in combination with various laser modalities for enhanced skin rejuvenation, pigmentation treatment, and overall dermal remodeling.

Introduction: Minimally invasive aesthetic treatments are evolving rapidly, with a growing demand for pain-free, efficient, and highly effective procedures. Needle-free jet injectors utilize high-pressure technology to deliver active compounds transdermally without the need for needles, reducing pain, downtime, and risk of complications. This presentation is to emphasise the synergistic effects of needle-free delivery of exosomes, tranexamic acid, ascorbic acid, and polynucleotides when combined with advanced picosecond lasers with DOE technology, CO₂ lasers, and other resurfacing modalities.

Materials / method: Patients underwent customized combination therapies using NovoJet or CureJet to infuse bioactive compounds transdermally. These treatments were paired with:
• Picosecond laser with DOE technology (for pigmentation and collagen stimulation)
• Fractional CO₂ laser (for resurfacing and deep dermal remodeling)
• Other resurfacing and tightening modalities

Treatment sessions were recorded, and clinical outcomes were documented through video demonstrations, high-resolution imaging, and patient feedback.

Results: Preliminary findings suggest enhanced absorption and deeper penetration of active compounds when using jet injectors compared to topical application. Patients reported reduced discomfort, minimal downtime, and faster recovery compared to traditional injection methods. Combination with picosecond and CO₂ lasers led to improved skin texture, increased collagen induction, and more effective pigment correction.

Conclusion: Third-generation needle-free jet injectors represent a significant advancement in aesthetic medicine, allowing for needle-free transdermal delivery of regenerative compounds with minimal patient discomfort. When paired with picosecond and CO₂ lasers, these treatments demonstrate superior efficacy, enhanced patient experience, and promising long-term skin benefits. Further studies are warranted to optimize protocols and expand applications in aesthetic dermatology.
This presentation will showcase live treatment videos demonstrating the real-time effectiveness of these innovative combinations.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Baz Biomedic

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
Por favor especifique las entidades (individuo, empresa, sociedad): Baz Biomedic

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Baz Biomedic, Fotona

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

DERMALUX - LED Phototherapy: Breakthrough Technology in Post-Surgical Recovery

TOP QUALITY - One device, more technologies, best results, a key word: SYNERGY.

Objectives: The objective of the present lecture is to show how a synergistic approach may improve treatment results.

Introduction: One device, more technologies, best results, a key word: SYNERGY. Top Quality Group’s products have always been focused on approaching medical treatments through different inputs. This scientifically leads to an increase in terms of results, thanks to the synergistic approach.

Materials / method: From the definition of Synergy, to the first quote on a medical library, until the present day use.
The synergy among different technologies allows to achieve more results: this is a Top Quality Group pillar and this has been shown in literature since the 19th century.

Results: During the years, Top Quality Group had the possibility to test different methods and approaches by combining more technologies in its product portfolio, in Aesthetic Medicine treatments, but also Gynecology, Physiotherapy, Dentistry and others, thus noticing how reaching a target via more combinations is fundamental.

Conclusion: Developing medical devices able to release different kinds of technologies leads to an optimization of the minimum effective dose needed for a treatment thus boosting the expected results. Furthermore, Top Quality Group also decided to position itself into the non-invasive technologies sector, therefore guaranteeing a high patient compliance.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): company

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: Top Quality Group S.r.l.

ENDYMED - Exploring new therapeutic synergies: Intensif and topical exosomes

BIODERMOGENESI - New therapeutic approach on skin aging: how to regenerate the tissue preserving the quality and reducing the impact of the side effects

Objectives: The aim of this study is to demonstrate the efficacy and safety of electromagnetic fields in tissue regeneration directed at skin aging.

Introduction: In the treatment of skin aging, aesthetic medicine has favoured therapies that cause damage to the skin, hoping to regenerate the tissue and temporary camouflage injections, designed to temporarily reshape volumes. The electromagnetic fields have shown their ability to repair and regenerate, thus promising interesting results in skin aging.

Materials / method: The study was conducted on XX patients aged between XX and XX, who underwent 5 VEMFtherapy sessions, one session per week, a therapy that combines the stimulation of electromagnetic fields to mechanical reduction of negative pressure.

Results: All patients had a clear aesthetic, but above all structural improvement, as shown by the normalization of sebum, pH and hydration of all tissue of face and neck. Over 90% of patients are very or extremely satisfied with the results, the comfort level was 9.28 on a scale from 0 to 10. No side effects or downtime were recorded; patients immediately resumed their lifestyles after the sessions.

Conclusion: The lack of side effects and downtime, the non-invasive and pleasant nature of the therapy, the evidence of aesthetic results and their uniformity, which involves the whole face and neck, but above all the restoration of biological values that determine skin age puts VEMFtherapy at a higher level than mere aesthetic medicine, entering right in pure regenerative medicine.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: BIODERMOGENESI®

MERZ AESTHETICS - Microfocused ultrasound with visualization (MFU-V): New advancements and clinical results

Objectives: To understand the mechanism of action for MFU-V.

Introduction: Regenerative aesthetics aims to restore youthful skin structure and function to skin and deeper tissues by leveraging the body's natural regenerative processes. Unlike implanted biomaterial fillers, energy-based devices (EBDs) trigger aesthetic improvement through the body's physiological response to treatment. This narrative review assessed evidence on microfocused ultrasound (MFU) in regenerative aesthetics.

Materials / method: A systematic search of PubMed, Scopus, and Web of Science identified relevant peer-reviewed articles up to July 2024. Two independent reviewers extracted and analyzed data, resolving discrepancies by consensus. Findings were synthesized narratively, emphasizing MFU's mechanism of action, efficacy, and safety.

Results: MFU-V emits ultrasound energy that penetrates multiple skin layers and the superficial musculoaponeurotic system, creating localized thermal coagulation points. These points trigger biological responses that recruit fibroblasts and stimulate the production of new collagen and elastin fibers. Enhanced extracellular matrix (ECM) protein synthesis results in significant improvements in skin biomechanics and quality. These findings are supported by clinical evidence, showing improvements in skin firmness and texture following MFU-V treatment.

Conclusion: In summary, MFU-V operates through mechanisms involving TCPs that induce collagen and elastin fiber regeneration, resulting in noticeable improvements in skin structure, firmness, and elasticity. While MFU demonstrates a capacity to remodel the extracellular matrix and improve skin biomechanics, further research is needed to fully elucidate its long-term impact and optimal use within the field of regenerative aesthetics, within diverse patient demographics, and in combination with other injectable treatments.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No
Por favor especifique las entidades (individuo, empresa, sociedad): Merz

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

TELEA MEDICAL - The power of quantum molecular resonance in anti ageing and regenerative medicine

Objectives: Quantum Molecular Resonance and Bioelectrics in Regenerative Medicine: Advancing Non-Invasive Cellular Therapies

Introduction: Recent advancements in regenerative medicine have expanded the use of bioelectric technologies to modulate cellular function and promote tissue repair. Quantum Molecular Resonance (QMR), a novel electromagnetic approach, utilizes precisely tuned frequency ranges to influence molecular interactions and enhance biological regeneration without invasive procedures or thermal damage. This presentation explores the principles of QMR and its synergy with bioelectrics, examining their role in stimulating fibroblast activity, enhancing collagen synthesis, and accelerating wound healing. Clinical applic

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo. telea med sponsored the imcas pass to speak at conference

SNJ - Fractional drug delivery of cosmetics using the SNJ Finexel CO₂ Laser: A breakthrough in skin rejuvenation

TECHNOLUX - Multifrax: The first and unique fractional non-ablative Laser, 1550nm & 1927nm wavelengths, with simultaneous emission

MARLLOR BIOMEDICAL - The science of ALIDYA: A groundbreaking approach to saying goodbye to cellulite

Objectives: Delegates attending this lecture will gain an understanding of the pathophysiology of cellulite and its link to iron toxicity, vascular dysfunction, and chronic inflammation. The session will demonstrate Alidya’s unique formula and its scientifically proven components—EDTA, amino acids, mannitol, bicarbonate, calcium ascorbate, and alpha-glucopyranose—and how they work synergistically to restore skin health, improve microcirculation, and visibly reduce cellulite. Practical insights into its application and clinical outcomes will be shared

Introduction: Cellulite affects 90% of post-pubertal women, characterized by skin dimpling and structural irregularities due to chronic inflammation, iron deposition, and ECM imbalance. Prof. Pasquale Motolese’s research identified iron toxicity as a critical factor in cellulite development, and this key finding was the basis for the development of Alidya. This medical device targets these underlying causes through chelation, detoxification, and tissue regeneration, offering a novel approach to this stubborn aesthetic problem..

Materials / method: The presentation will summarize clinical and histological data, including biopsies analysed using PERLS staining, which confirmed iron and hemosiderin deposits in cellulite-affected tissues. Results from recent multicenter studies using thermography, HD ultrasound, and body measurements will highlight the efficacy of Alidya in reducing oedema, improving skin texture, and restoring ECM balance. Application protocols and patient outcomes will also be discussed.

Conclusion: Alidya represents a ground-breaking injectable therapy targeting the root causes of cellulite. By addressing iron toxicity, oxidative stress, and chronic inflammation, it restores tissue physiology, enhances collagen production, and reduces visible irregularities. Clinical evidence supports its efficacy, demonstrating smoother, healthier skin and improved patient satisfaction. After more than 10 years in the aesthetic market, this innovative solution provides a scientifically backed approach to managing cellulite

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Marllor Biomedical

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
No

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo es presentado gracias al apoyo de: Marllor Biomedical

RENAISSANCE - Enhancing lipolytic efficiency: Integrating painfree chemical lypolisys with a multitasking lipase-driven formula and plant exosomes for a dual-action fat breakdown

TEMA MEDICINA - Attiva: Retrospective review and advanced techniques

SHANGHAI MAY SKIN - Skin analyzer 3D Era: 3-in-1 cutting-edge 3D full-face imaging technology catering to the needs of both dermatologists and cosmetic surgeons

ISKRA MEDICAL - Tesla Former in the hands of a surgeon

ISKRA MEDICAL - The use of magnetic stimulation for pelvic floor dysfunction and noninvasive body contouring

Objectives: To evaluate the role of magnetic stimulation (MS) in the treatment of urinary incontinence (UI) based on 10 years of clinical research, supported by two systematic reviews (SRs). The study aimed to assess the efficacy, safety, and patient experiences with MS for different types of UI, focusing on the outcomes of clinical studies and SR findings.

Introduction: Urinary incontinence (UI) significantly impacts quality of life, and MS offers a non-invasive, conservative treatment option. Approved by the FDA in 1998, MS is gaining attention due to its patient acceptability and minimal side effects. However, evidence supporting its long-term efficacy remains weak. The 2020 European Urology Association (EUA) guidelines advised against MS for UI or overactive bladder (OAB), but the 2024 guidelines no longer contain this recommendation. This study presents 10 years of clinical experiences and evaluates MS as a treatment option for female UI through clinical

Materials / method: This research includes two clinical studies and two systematic reviews (SR) conducted over the past decade.
Study 1: A prospective non-randomized study of 75 patients with stress urinary incontinence (SUI), mixed urinary incontinence (MUI), or urgency urinary incontinence (UUI) with a 3-month follow-up.
Study 2: A prospective randomized, sham-controlled trial (RCT) involving 40 UUI patients randomized in a 2:1 ratio (active:sham). Follow-up was conducted after 6 months.
SRs were conducted per PRISMA guidelines to assess the efficacy and side effects of MS.

Results: In Study 1, MS improved UI across all types, with the greatest reduction in ICIQ-UI SF scores observed in SUI patients.
In Study 2, a statistically significant improvement (p=0.034) in ICIQ-UI SF scores was noted within the active treatment group at 6 months compared to baseline. A significant difference between the active and sham groups further confirmed the efficacy of MS for UUI.
SRs highlighted the lack of standardized MS protocols regarding stimulation parameters, therapy duration, and follow-up.

Conclusion: Magnetic stimulation is an effective, safe, and painless treatment option for UI, particularly in patients who cannot tolerate or do not respond to medication or surgery. It provides an alternative for patients unwilling or unable to use electrostimulation devices or perform pelvic floor exercises. MS holds promise as a first-line treatment for UI and could complement other energy-based devices in addressing the integral theory of UI. However, further clinical trials are needed to define optimal stimulation parameters, duration, and standardized protocols for maximizing treatment efficacy.

Declaraciones

¿Ha recibido algún tipo de financiamiento para realizar su investigación sobre esta temática?
No

¿Ha recibido algún pago, honorario u otra compensación por su trabajo acerca de esta investigación?
No

¿Tiene vínculos financieros con alguna entidad que podría llegar a competir estrechamente con los medicamentos, materiales o instrumentos tratados en su investigación?
Si
Por favor especifique las entidades (individuo, empresa, sociedad): Speaker for Iskra Medical

¿Posee o ha solicitado una patente relacionada a los materiales, productos o instrumentos utilizados en su investigación?
No

Este trabajo no cuenta con el apoyo de ningún financiamiento directo o indirecto. El autor asume plena responsabilidad sobre el mismo.

Horas	Oradores	Título de la presentación	Resumen	Número
08:30		Cosmeceuticals & Nutraceuticals		145353
08:30	Prof Firas AL NIAIMI	CAMPOMATS - Microneedling for regenerative medecine through cosmeceuticals delivery		139047
08:45	Dr Robert CHMIELEWSKI	LABORATOIRES URGO - Smart DNA therapy: Antioxidant and anti-inflammatory therapy to support and modulate the natural skin microbiome. Protection and repair of skin cell DNA. Clinical case study by Retix.C		139045
09:00	Miriam MARTINEZ CALLEJAS	ROSEWAY LABS - Personalised skincare using compounded medication	Ver	139032
09:15	Dr Xavier GOODARZIAN	DERMOAROMA - Purasomes XCell : Improving clinical outcome with new generation of bovine colostrum sublingual supplement		139101
09:30	Dr Tanja RADENKOV MEDENICA	EURORESEARCH - Collagen overwiev		139010
09:45	Dr Paris ACHARYA	CANTABRIA LABS - All skin med: Dispensing doctor cosmetic range and its new solutions to activate and reinforce the skin barrier function		139008
10:00	Marie RENAULT	ROC SKINCARE - RoC35: 35 French clinics researching the ultimate skin rejuvenation skincare routine		139006
10:15		Hair Restoration		145354
10:15	Dr Gustavo TORRES DE SOUZA	FAGRON GENOMICS - SNP association analysis: A novel pathway towards personalised treatment for androgenetic alopecia		139035
10:30	Dr Nikica MARINIC	INSTITUTE BCN - Duo-Action PRP: Enhancing hair loss and alopecia treatment with botox and meostherapy		139005
10:45	Faye ASTON	DERMAROLLER - Revolutionizing skin and hair care: The next-gen microneedling device and hair growth science		139042
11:00		Threads		145359
11:00	Dominique MALARD	SPRING THREAD - Permanent / Resorbable : Why and how to choose the best aesthetic thread according to your patient request or indication		139031
11:15		Regenerative Medicine		145358
11:15	Dr Lobna BADR GAMAL	REGENERA ACTIVA - EVOlution of autologous micrografting; 3rd generation of rigenera techology		139009
11:30	Dr Cristina MUNTEAN	DERMOAROMA - Bovine colostrum secretomes application in regenerative and functional gynaecology		139007
11:45	Dr Marwa ZEIN ABEDIN	DERMOAROMA - Unlocking bio rejuvenation with bovine colostrum secretomes		145449
12:00	Dr Vladlena Igorevna AVERINA	PLURYAL - Portrait of patients for polynucleotides and exosomes		145453
12:15	Dr Gian Rocco CARFAGNA	RENAISSANCE - Accelerated regeneration : Integrating PDRN & exosomes therapy with MIO-Modulated pulse stimulation for enhanced skin cellular renewal		145385
12:30	Dr Noura LEBBAR	ALLIER PARIS - Discover the science behind enjoue: The new generation of whitening, lifting & bio revitalizing	Ver	139090
12:45		Lasers, EBD & Body Shaping		145360
12:45	Kingsley MARIADASAN	BAZ BIOMEDIC - Innovative combination therapies utilizing Needle-Free Jet Injector	Ver	139053
13:00	Prof Roberto AMORE	LOVE COSMEDICAL - Chemical Reduction of unwanted fat deposits		139093
13:15	Dr Meghna GUPTA	CAMPOMATS - RFNEED System: a new device to deliver products in regenerative medicine		139082
13:30	Dr Georgios CHRISTOPOULOS	DERMALUX - LED Phototherapy: Breakthrough Technology in Post-Surgical Recovery		139050
13:45	Martina GRILLI	TOP QUALITY - One device, more technologies, best results, a key word: SYNERGY.	Ver	139049
14:00	Dr Marco BARTOLUCCI	ENDYMED - Exploring new therapeutic synergies: Intensif and topical exosomes		139048
14:15	Dr Simona LAURA	BIODERMOGENESI - New therapeutic approach on skin aging: how to regenerate the tissue preserving the quality and reducing the impact of the side effects	Ver	139041
14:30	Dr Jennifer LEVINE	MERZ AESTHETICS - Microfocused ultrasound with visualization (MFU-V): New advancements and clinical results	Ver	139039
14:45	Dr Surbhi VIRMANI	TELEA MEDICAL - The power of quantum molecular resonance in anti ageing and regenerative medicine	Ver	139034
15:00	Dr Gabriel BUENDIA BORDERA	SNJ - Fractional drug delivery of cosmetics using the SNJ Finexel CO₂ Laser: A breakthrough in skin rejuvenation		139003
15:15	Dr Nikolai TANKOVICH	TECHNOLUX - Multifrax: The first and unique fractional non-ablative Laser, 1550nm & 1927nm wavelengths, with simultaneous emission		139054
15:30	Dr Arturo ALMEIDA	MARLLOR BIOMEDICAL - The science of ALIDYA: A groundbreaking approach to saying goodbye to cellulite	Ver	145441
15:45	Dr Siegfried SCHMIDT	RENAISSANCE - Enhancing lipolytic efficiency: Integrating painfree chemical lypolisys with a multitasking lipase-driven formula and plant exosomes for a dual-action fat breakdown		145443
16:00	Dr Jack ZAMORA	TEMA MEDICINA - Attiva: Retrospective review and advanced techniques		145447
16:15	Dr Snoor Subhi HADI	SHANGHAI MAY SKIN - Skin analyzer 3D Era: 3-in-1 cutting-edge 3D full-face imaging technology catering to the needs of both dermatologists and cosmetic surgeons		145460
16:30	Dr Matthieu BEUSTES STEFANELLI	ISKRA MEDICAL - Tesla Former in the hands of a surgeon		139020
16:45	Dr David LUKANOVIC	ISKRA MEDICAL - The use of magnetic stimulation for pelvic floor dysfunction and noninvasive body contouring	Ver	145549
17:00	Dr Sanja LATKOSKA	ISKRA MEDICAL - Advantages of Tesla Former -4		145561
17:15	Clara SERES	ASIROX - Use of Diode laser beyond hair removal		145637
17:30	Dr Arnaud LAMBERT	VYDENCE - Prodeep and HandPico combination		145701
17:45	Simon JONES	NEOGEN - Nitrogen plasma, a 360 approach to skin regeneration		145824

IMCAS World Congress 2025
Programa

Open Stage - Industry sponsored lectures

Las presentaciones

IMCAS World Congress 2025 Programa

Open Stage - Industry sponsored lectures

Las presentaciones

IMCAS World Congress 2025
Programa